Avacopan for treating anti-neutrophil cytoplasmic antibody-associated vasculitis [ID1178]
Discontinued
Reference number: GID-TA10199
The consultation on the draft scope closed on Tuesday 15 August 2017. The company that markets the technology has advised that the regulatory filing strategy for this product is delayed and still under consideration. NICE has agreed that a scoping workshop would not be appropriate at this time. As a consequence of this the scoping workshop arranged for 15 September 2017 has been cancelled. We apologise for any inconvenience this may cause.